Mercer Global Advisors »

Vir Biotechnology shares owned by Mercer Global Advisors

Quarter-by-quarter ownership of Vir Biotechnology (VIR) shares owned by Mercer Global Advisors from 13F filings

Historical chart of Mercer Global Advisors investment in Vir Biotechnology

Tip: Access up to 7 years of quarterly data

All positions including Vir Biotechnology held by Mercer Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vir Biotechnology by Mercer Global Advisors

Quarter filed Position value Share count Share price at filing
2023-06-30 $1.2M 48k 24.54
2023-03-31 $924k 40k 23.26
2022-12-31 $908k 36k 25.32
2022-09-30 $664k 35k 19.27

More positions owned by Mercer Global Advisors

Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Ishares Tr Msci Usa Mmentm (MTUM)
Apple (AAPL)
Dimensional Etf Trust Us Mktwide Value (DFUV)
Vanguard Tax-managed Intl Ftse Dev M (VEA)
Vanguard Charlotte Fds Intl Bd Idx Etf (BNDX)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Min Vol (USMV)
Dimensional Etf Trust Us High Profitab (DUHP)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Shrt Nat Mun Etf (SUB)
Ishares Tr Msci Intl Moment (IMTM)

View all positions for Mercer Global Advisors

Top funds holding Vir Biotechnology

Vanguard Group
Baillie Gifford & Co
Citadel Advisors
Alliancebernstein
Bill & Melinda Gates Foundation
D. E. Shaw & Co
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Voloridge Investment Management
UBS Group
Principal Financial Group
Dimensional Fund Advisors
Barclays
Millennium Management

View all funds holding Vir Biotechnology